Masaomi Miyamoto

Masaomi Miyamoto, Ph.D

Executive Vice President of R&D and Operations

APRINOIA Japan

  • Managing Director, Seikagaku, Japan
  • General Manager, Director for Drug Discovery, Takeda, Japan
  • Ph.D, Kyushu University, Japan
  • MS in Pharmaceutical Sciences, Kyushu University, Japan
  • CNS pharmacology, Alzheimer’s disease and sleep disorder, drug development: TRH-T (Hiltonin™), idebenone (Avan™), ramelteon (Rozerem™)